Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Internet Revolution: Implications for Pharma

This article was originally published in Start Up

Executive Summary

Big Pharma has been generally cautious in developing Internet capabilities and strategies: most companies are only selectively applying Web technologies to their existing business models. The Internet opens many potential opportunities for drug companies, including streamlining procurement & manufacturing, sharing R&D knowledge through virtual communities, enhancing clinical development productivity, and developing new techniques for marketing to consumers and physicians. To design and execute an effective Internet strategy, companies need to develop in-house capabilities in six categories: continuous strategy development; rapid decisionmaking and resource allocations; e-commerce dealmaking; best in market sourcing; technology architecture; and performance-driven management.
Advertisement

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC090134

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel